Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Regeneron Pharmaceuticals Inc (REGN), JDS Uniphase Corp (JDSU), PulteGroup, Inc. (PHM): Today’s Three Best Stocks

It hasn’t happened nearly as often as optimists would like to see in recent weeks, but improving economic data matched the move higher in the broad-based S&P 500 today, and gave new life to bulls that this correction may indeed be nothing more than a blip in a continuous uptrend.

The big news today was the weekly jobless claims report, which delivered a drop of 11,000 from the previous week to a seasonally adjusted 346,000. There’s certainly going to be some fluctuation in these figures, but anything below 400,000 is widely believed to be a sign of a strengthening job market by economists.

Although there were some wild swings today in the S&P 500, the index ultimately finished the day higher, by 13.66 points (0.85%), to close at 1,622.56. As you might expect, following the large two-day drop for the markets, there were quite a few big movers today.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Biotechnology superstar Regeneron Pharmaceuticals Inc (NASDAQ:REGN) topped the charts, tacking on 9.8% after it, and partner Bayer, reported positive late-stage results for Eylea in treating myopic choroidal neovascularization, or mCNV. In trials, those patients receiving Eylea had a mean improvement in best-corrected visual acuity of 12.1 letters after 24 weeks compared to the control arm, which delivered a loss of two letters. Eylea is already a blockbuster drug approved by the Food and Drug Administration to treat wet age-related macular degeneration and macular edema following central retinal vein occlusion, and now looks poised to add a third indication in treating mCNV. With baby boomers now reaching retirement age, the need for ophthalmic treatments is only going to increase, putting Regeneron Pharmaceuticals Inc (NASDAQ:REGN) in the driver’s seat.

Shares of fiber optic company JDS Uniphase Corp (NASDAQ:JDSU) shot higher by 8.4%, led by peer Ciena Corporation (NASDAQ:CIEN), which surged after it topped Wall Street’s expectations in the second quarter and forecast third-quarter revenue well above the consensus. What’s really noteworthy about Ciena Corporation (NASDAQ:CIEN)’s quarter was that the majority of revenue growth came from the U.S., not overseas. This speaks to what I’ve been saying for months about the next cycle of infrastructure growth trickling down from service providers like AT&T Inc. (NYSE:T) down to fiber optic companies like JDS Uniphase Corp (NASDAQ:JDSU), and into individual networking parts providers. We are witnessing the next boom in infrastructure spending, and I don’t feel it’s anywhere near too late to still get in on the gains.

Finally, homebuilder PulteGroup, Inc. (NYSE:PHM) rallied 4.7%, in spite of no company-specific news. This appeared to be more of a rebound rally than anything else, as investors have demonstrated their concerns in recent days about whether the rally in homebuilders was too much, too soon. While home prices have been strong, and inventories remain low, the prospect of the Federal Reserve’s bond-buying program tapering off sooner than later could stymie loan growth, and bring the housing sector to a grinding halt. I certainly feel the risk far outweighs the reward with PulteGroup, Inc. (NYSE:PHM) at the moment.

The article Today’s 3 Best Stocks originally appeared on and is written by Sean Williams.

Fool contributor Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!